编织袋里装百万现金送医院院长、1名医生收6家医药公司药品回扣款国家医保局密集披露多起医药商业贿赂案

Group 1 - Chongqing Kangrong Medical Equipment Co., Ltd. was involved in a commercial bribery case amounting to 8 million yuan, the largest reported case recently [1] - The actual controller of Kangrong Medical, Wang, paid bribes to the hospital director, Sun, five times from 2015 to 2023 to secure business advantages [1] - The National Healthcare Security Administration (NHSA) has reported multiple cases of commercial bribery in the medical field, highlighting issues such as information asymmetry and weak compliance awareness [1][2] Group 2 - Kangrong Medical has participated in 22 bidding projects, primarily between 2018 and 2020, with a registered capital of 960,000 yuan [2] - The NHSA stated that the bribes paid by Kangrong Medical would inflate the costs of medical products, harming fair competition and squeezing out compliant businesses [2] - The Chongqing Medical Insurance Bureau has classified Kangrong Medical's actions as "seriously untrustworthy," suspending its distribution qualifications in the Chongqing medical procurement market for five years [2] Group 3 - Other recent cases of medical commercial bribery have been reported, including a doctor receiving 789,100 yuan in kickbacks from pharmaceutical companies over 11 years [3] - The Shanghai Haiyilai Enterprise Consulting Management case involved a promise of kickbacks to doctors for prescribing a specific drug, totaling 35,046 yuan in payments [4][5] - The evolution of bribery methods in the medical field has shifted from overt cash payments to more covert and professionalized forms of benefit delivery, complicating regulatory oversight [5]